Dongping Tu
Impact in
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 8
- Cancer Treatment and Pharmacology 5
- Colorectal Cancer Treatments and Studies 3
-
- Plant biochemistry and biosynthesis 3
- Co-authors
- Lesley Seymour (3 shared papers)S. Thongprasert (1 shared paper)Vera Hirsh (1 shared paper)Tudor–Eliade Ciuleanu (1 shared paper)Ee Hong Tan (1 shared paper)José Rodrigues Pereira (1 shared paper)Frances A. Shepherd (1 shared paper)Andrea Bezjak (1 shared paper)
In The Last Decade
Dongping Tu
25 papers receiving 440 citations
Peers
Comparison fields: 5 of 90
- Oncology 263
- Pulmonary and Respiratory Medicine 210
- Cancer Research 60
- Molecular Biology 139
- Hepatology 14
Countries citing papers authored by Dongping Tu
This map shows the geographic impact of Dongping Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongping Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongping Tu more than expected).
Fields of papers citing papers by Dongping Tu
This network shows the impact of papers produced by Dongping Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongping Tu. The network helps show where Dongping Tu may publish in the future.
Co-authors
The 25 scholars most cited alongside Dongping Tu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 212 | |
| 2 | 2005 | 41 | |
| 3 | 2015 | 34 | |
| 4 | 2016 | 23 | |
| 5 | 1996 | 22 | |
| 6 | 2001 | 21 | |
| 7 | An international multicentre Phase III study of BAY 12-9566 (BAY) versus placebo in patients (pts) with advanced ovarian cancer (OVCA) responsive to primary surgery/Paclitaxel + Platinum containing chemotherapy (CT) | 2001 | 15 |
| 8 | 2006 | 14 | |
| 9 | 2017 | 14 | |
| 10 | 2019 | 10 | |
| 11 | 2016 | 8 | |
| 12 | 2022 | 5 | |
| 13 | 2016 | 5 | |
| 14 | 2020 | 4 | |
| 15 | 2024 | 4 | |
| 16 | 2015 | 4 | |
| 17 | 2011 | 3 | |
| 18 | 2011 | 3 | |
| 19 | Morphological and endogenous hormones characteristics of flower bud of Siraitia grosvenorii during its differentiation. | 2015 | 2 |
| 20 | 2017 | 2 |
About Dongping Tu
Dongping Tu is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Nutrition and Dietetics, having authored 25 papers that have together received 455 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (5 papers), Biochemical Analysis and Sensing Techniques (5 papers), Breast Cancer Treatment Studies (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Plant biochemistry and biosynthesis (3 papers), Advanced Breast Cancer Therapies (3 papers), Gastric Cancer Management and Outcomes (3 papers) and Plant Molecular Biology Research (2 papers). The work is most often cited by research in Oncology (263 citations), Pulmonary and Respiratory Medicine (210 citations), Cancer Research (60 citations), Molecular Biology (139 citations) and Hepatology (14 citations). Dongping Tu has collaborated with scholars based in China, Canada and Australia. Frequent co-authors include Lesley Seymour, S. Thongprasert, Vera Hirsh, Tudor–Eliade Ciuleanu, Ee Hong Tan, José Rodrigues Pereira, Frances A. Shepherd, Andrea Bezjak, Xiaojun Ma and Changming Mo. Their work appears in journals such as Journal of Clinical Oncology, Acta Pharmaceutica Sinica B, Cancer Research, British Journal of Cancer and RSC Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.